Insider Trading & Ownership of Royalty Pharma plc
-
Location
-
New York, NY
-
Signature
-
/s/ Sean Weisberg, as Attorney-in-Fact for Vlad Coric
Follow Filing Activity
Follow Royalty Pharma plc and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Quick Takeaways
- Royalty Pharma plc has 1 issuer position tracked on this page.
- Estimated disclosed ownership value is not available.
- No recent insider transactions are currently listed.
What Changed
- Largest disclosed position: Royalty Pharma plc ($0).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing
Continue ownership research
Ownership of Royalty Pharma plc
| Symbol |
Company |
Relationship |
Holdings Value |
Past Year Net Change |
Change % |
Report Period |
| RPRX |
Royalty Pharma plc |
Director |
$0 |
|
|
07 Apr 2025 |
There are no insider transactions reported by Royalty Pharma plc